Corona Remedies IPO Listing: Stock Lists at 38% Premium on NSE
Corona Remedies IPO: A Blockbuster Debut with a 38% Listing Premium Corona Remedies, one of the fastest-growing major pharmaceutical companies in India, made a spectacular debut on the...
